NOSOSEPT 100

Surface broad spectrum fast acting disinfection spray

NOSOSEPT 100 is a ready-to-use, broad-spectrum antimicrobial surface disinfectant spray, developed for the rapid cleaning and disinfection of non-invasive medical device surfaces.

With a validated contact time of 30 seconds, its routine application between patient sessions contributes to effective infection control and supports the prevention of cross- contamination.

NOSOSEPT 100 is intended for use on medical device surfaces in direct contact with patients and healthcare personnel, including trolleys, benches, examination tables, and operating room furniture.

The formulation provides high antimicrobial performance, low odour, and residue-free drying, ensuring suitability for frequent application in clinical settings.

Properties

  • Active in 30 seconds
  • Does not affect the medical equipment
  • Bactericidal, fungicidal, tuberculocidal, mycobactericidal
  • Virucidal (HBV, HIV, HCV, Herpes, Vaccinia, BVDV, Influenza, Εbola, Coronavirus, Rotavirus,...)
  • Does not contain phenols, aldehydes, chlorine or EDTA
  • Residue-free drying for clean, streak-free surfaces

Microbiological efficacy

NOSOSEPT 100 - Microbiological efficacy


* Including all antibiotic resistant bacteria such as MRSA, Escherichia coli, Klebsiella pneumoniae, Streptococcus pneumoniae, etc.)
(1) DVV: Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten / German Association for the Control of Virus Diseases
(2) RKI: Robert Koch Institute – German Federal Health Authority

NOSOSEPT 100 - Surface broad spectrum fast acting disinfection spray

Packaging

  • 1 litre spray bottle (Ref. 20003)
  • 5 litre canister (Ref. 20004)

Physical properties

  • Appearance: Transparent solution
  • Density: 0.97 g/cm3 at 20˚C
  • pH: 9.0-9.6 at 20˚C
  • Odour: Mild (alcohol)
  • Storage: 5˚C – 35˚C
  • Stability: 3 Years
  • Biodegradability: According to OCDE 301D

Composition

Isopropyl alcohol, didecyldimethyl ammonium chloride,
N- (3-aminopropyl) -N dodecylpropano-1,3-diamine, excipients.

NOSOSEPT 100 is manufactured in the EU.
MEDALKAN satisfies the requirements of ISO 9001 for quality management system and the requirements of ISO 13485 for the design and manufacture of medical devices.

ISO Certification
  • CE mark according to the medical devices Directive
    (Directive 93/42/EEC)
  • Medical device class IIa